U.S. reviewing safety of Glaxo, Bristol AIDS drugs (Reuters)
Reuters - U.S. health officials are reviewing
the safety of AIDS drugs sold by GlaxoSmithKline Plc and
Bristol-Myers Squibb Co after a study showed a higher
heart-attack risk compared with other HIV medicines, the Food
and Drug Administration sai [...]











